Reports

As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.

Global Neutropenia Treatment Market: By Treatment: Colony-stimulating factors, Antibiotics, Antifungals, Antivirals; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Neutropenia Treatment Market Outlook

The global neutropenia treatment market reached a value of about USD 13.4 billion in 2020. The market is projected to grow at a CAGR of 5.4% during the forecast period of 2022-2027 to attain a value of nearly USD 18.3 billion by 2026.

 

Increasing Awareness of Neutropenia and Side-effects of Chemotherapy to Augment the Market Growth

In the forecast period, rising awareness of neutropenia and chemotherapy-related side effects, as well as increasing diagnostic technologies, are expected to help accelerate the rise of neutropenia treatment. The significant increase is attributed to a promising therapeutic pipeline that includes around 5 medicines in phase III clinical studies to treat neutropenia. The risk of neutropenia is predicted to increase as the prevalence of leukaemia rises, particularly after treatment.

 

Global Neutropenia Treatment Marke

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

One of the major drivers of market expansion is new therapies paired with an increase in occurrences of chemotherapy-induced neutropenia. Furthermore, the innovative medication delivery technique improves patient comfort, resulting in increased patient adherence and, as a result, market growth. Furthermore, because cancer is a known cause of neutropenia, the market for neutropenia treatment will benefit from an increase in the number of instances of chemotherapy for cancer treatment.

 

North America Accounted for the Largest Share While the Asia Pacific is the Fastest Growing Region in the Market

In the worldwide neutropenia treatment industry, North America held the biggest share. North America has had tremendous expansion in the neutropenia treatment industry, and it is likely to dominate the market in the future years. This is due to an increase in the number of cases of leukaemia in the area. In addition, North America is home to many of the market's main participants. Furthermore, the United States dominates the need for neutropenia therapy in North America. The region's dominance is attributable to an increase in demand for febrile neutropenia medications and the implementation of new legislation to promote and manufacture biosimilars. Throughout the forecast period, the Asia Pacific is predicted to develop at the fastest rate in the market. Due to the increasing number of leukaemia cases and patients undergoing first-line chemotherapy treatment in Asia, the neutropenia treatment industry has a lot of room to grow.

 

Neutropenia Treatment: Industry Definition and Segmentation

Neutropenia is a rare disease characterised by a sharp drop in neutrophil counts, resulting in weakened immunity. Neutropenia can be caused by a variety of diseases or situations, including chemotherapy for cancer, infections, congenital bone marrow abnormalities, autoimmune disorders, and some medications (drug-induced neutropenia).

On the basis of treatment, neutropenia treatment industry is segmented into:

  • Colony-stimulating factors 
  • Antibiotics
  • Antifungals
  • Antivirals

Based on the distribution channel, the market is divided into:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

The major regional markets of neutropenia treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Increasing Focus on Research and Development Activities by Companies to Bolster the Market Growth

The neutropenia treatment industry is expected to increase considerably due to major players in the industry supporting research and development as well as public awareness of neutropenia therapy. Companies in this market are focusing on raising knowledge about preventive measures, early diagnosis, and effective treatment of neutropenia as major market tactics. The introduction of small molecules is one of the major technologies gaining traction in the worldwide neutropenia treatment industry. The development of Plinabulin, a tiny chemical with immune-boosting properties created by BeyondSpring Pharmaceuticals, is expected to transform neutropenia treatment. In addition to its immune-boosting properties, Phase II tests have shown that this chemical has even more effective anti-cancer properties. In the neutropenia treatment industry, there is now a significant need for cost-effective medicines. As a result, suppliers are concentrating their efforts on the development of small molecules that have lower processing costs than biologics.

 

Key Industry Players in the Global Neutropenia Treatment Market

The report gives a detailed analysis of the following key players in the global neutropenia treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Amgen, INC.
  • Beyondspring, INC.
  • Cellerant Therapeutics, Inc.
  • Kyowa Kirin 
  • Pfizer INC. 
  • Novartis Ag 
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2020
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Treatment, Distribution Channel, Region
Breakup by Treatment Colony-stimulating factors, Antibiotics, Antifungals, Antivirals
Breakup by Distribution Channel Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Amgen, INC., Beyondspring, INC., Cellerant Therapeutics, Inc., Kyowa Kirin, Pfizer INC., Novartis Ag, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Neutropenia Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Neutropenia Treatment Historical Market (2017-2021) 
    8.3    Global Neutropenia Treatment Market Forecast (2022-2027)
    8.4    Global Neutropenia Treatment Market by Treatment
        8.4.1    Colony-stimulating factors 
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Antibiotics
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Antifungals
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
        8.4.4    Antivirals
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2017-2021)
            8.4.4.3    Forecast Trend (2022-2027)
    8.5    Global Neutropenia Treatment Market by Distribution Channel
        8.5.1    Hospital Pharmacies  
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Retail Pharmacies 
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Online Pharmacies 
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
    8.6    Global Neutropenia Treatment Market by Region
        8.6.1    Market Share
            8.6.1.1    North America
            8.6.1.2    Europe
            8.6.1.3    Asia Pacific
            8.6.1.4    Latin America
            8.6.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    EMR’s Key Indicators for Demand
    10.4    EMR’s Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Amgen, INC.
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Beyondspring, INC.
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3     Cellerant Therapeutics, Inc.
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Kyowa Kirin 
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Pfizer INC. 
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Novartis Ag 
            12.2.6.1    Company Overview
            12.2.6.2    Product Portfolio
            12.2.6.3    Demographic Reach and Achievements
            12.2.6.4    Certifications
        12.2.7    Others
13    Industry Events and Developments

 

List of Figures and Tables

1.    Global Neutropenia Treatment Market: Key Industry Highlights, 2016 and 2026
2.    Global Neutropenia Treatment Historical Market: Breakup by Treatment (USD Billion), 2017-2021
3.    Global Neutropenia Treatment Market Forecast: Breakup by Treatment (USD Billion), 2022-2027
4.    Global Neutropenia Treatment Historical Market: Breakup by Distribution Channel (USD Billion), 2017-2021
5.    Global Neutropenia Treatment Market Forecast: Breakup by Distribution Channel (USD Billion), 2022-2027
6.    Global Neutropenia Treatment Historical Market: Breakup by Region (USD Billion), 2017-2021
7.    Global Neutropenia Treatment Market Forecast: Breakup by Region (USD Billion), 2022-2027
8.    North America Neutropenia Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
9.    North America Neutropenia Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
10.    Europe Neutropenia Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
11.    Europe Neutropenia Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
12.    Asia Pacific Neutropenia Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
13.    Asia Pacific Neutropenia Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
14.    Latin America Neutropenia Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
15.    Latin America Neutropenia Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
16.    Middle East and Africa Neutropenia Treatment Historical Market: Breakup by Country (USD Billion), 2017-2021
17.    Middle East and Africa Neutropenia Treatment Market Forecast: Breakup by Country (USD Billion), 2022-2027
18.    Global Neutropenia Treatment Market Structure

Key Questions Answered in the Report

In 2020, the global neutropenia treatment market attained a value of nearly USD 13.4 billion.

The market is projected to grow at a CAGR of 5.4% between 2021 and 2026.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 18.3 billion by 2026.

The major drivers of the industry, such as rise in cancer cases leading to development of novel therapies and increasing number of R&D and investments by major players are expected to aid the market growth.

The key market trends guiding the growth of the industry include rising awareness of neutropenia and chemotherapy-related side effects, as well as increasing diagnostic technologies.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America dominating the market share in regional markets.

Colony stimulating factors segment is expected to be the dominant treatment in the industry due to the presence of major players who are focused on the development of colony-stimulating factor based drugs.

The distribution channel segment is led by hospital pharmacies segment of the market.

The major players in the industry are Amgen, INC., Beyondspring, INC., Cellerant Therapeutics, Inc., Kyowa Kirin, Pfizer INC., and Novartis Ag, among others.

Analyst Review

The global neutropenia treatment market attained a value of about USD 13.4 billion in 2020, driven by the rise in cancer cases leading to development of novel therapies. Aided by the rising awareness of neutropenia and chemotherapy-related side effects, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 5.4%. The market is projected to reach nearly USD 18.3 billion by 2026.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on treatment, the neutropenia treatment industry can be segmented into colony-stimulating factors, antibiotics, antifungals, and antivirals. On the basis of distribution channel, the industry is divided into hospital pharmacies, retail pharmacies, and online pharmacies. The major regional markets for neutropenia treatment are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America dominating the market share. The key players in the above market include Amgen, INC., Beyondspring, INC., Cellerant Therapeutics, Inc., Kyowa Kirin, Pfizer INC., and Novartis Ag, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

RIGHT PEOPLE

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

RIGHT METHODOLOGY

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

RIGHT PRICE

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

RIGHT SUPPORT

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

Similar Reports





NEWSLETTER